Click here to get full coverage on RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease - Zacks Investment Research

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease  Zacks Investment Research

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease - Zacks Investment Research

Click here to get full coverage on RCKT (Rocket Pharmaceuticals) asks shareholders to elect directors, ratify auditor, approve option exchange - Stock Titan

RCKT (Rocket Pharmaceuticals) asks shareholders to elect directors, ratify auditor, approve option exchange  Stock Titan

RCKT (Rocket Pharmaceuticals) asks shareholders to elect directors, ratify auditor, approve option exchange - Stock Titan

Click here to get full coverage on Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery - Yahoo Finance

Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery  Yahoo Finance

Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery - Yahoo Finance

Click here to get full coverage on Rocket Pharma Advances Cardiac Gene Therapy Trial, Keeping RCKT on Investors’ Radar - TipRanks

Rocket Pharma Advances Cardiac Gene Therapy Trial, Keeping RCKT on Investors’ Radar  TipRanks

Rocket Pharma Advances Cardiac Gene Therapy Trial, Keeping RCKT on Investors’ Radar - TipRanks

Click here to get full coverage on Needham Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating - Moomoo

Needham Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating  Moomoo

Needham Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating - Moomoo

Click here to get full coverage on Rocket Pharmaceuticals, Inc. $RCKT Shares Acquired by JPMorgan Chase & Co. - MarketBeat

Rocket Pharmaceuticals, Inc. $RCKT Shares Acquired by JPMorgan Chase & Co.  MarketBeat

Rocket Pharmaceuticals, Inc. $RCKT Shares Acquired by JPMorgan Chase & Co. - MarketBeat

Click here to get full coverage on Rocket Pharma wins FDA nod for gene therapy (update) - Seeking Alpha

Rocket Pharma wins FDA nod for gene therapy (update)  Seeking Alpha

Rocket Pharma wins FDA nod for gene therapy (update) - Seeking Alpha

Click here to get full coverage on $RCKT stock is up 12% today. Here's what we see in our data. - Quiver Quantitative

$RCKT stock is up 12% today. Here's what we see in our data.  Quiver Quantitative

$RCKT stock is up 12% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on RCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off - Stocktwits

RCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off  Stocktwits

RCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off - Stocktwits

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position - Yahoo Finance

Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position  Yahoo Finance

Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position - Yahoo Finance

Click here to get full coverage on RCKT Stock Jumps Over 10% Premarket: FDA Approves Its First Gene Therapy For Rare Childhood Immune Disease - Stocktwits

RCKT Stock Jumps Over 10% Premarket: FDA Approves Its First Gene Therapy For Rare Childhood Immune Disease  Stocktwits

RCKT Stock Jumps Over 10% Premarket: FDA Approves Its First Gene Therapy For Rare Childhood Immune Disease - Stocktwits

Click here to get full coverage on [SC TO-C] ROCKET PHARMACEUTICALS, INC. Tender Offer Communication | RCKT SEC Filing - Form SC TO-C - Stock Titan

[SC TO-C] ROCKET PHARMACEUTICALS, INC. Tender Offer Communication | RCKT SEC Filing - Form SC TO-C  Stock Titan

[SC TO-C] ROCKET PHARMACEUTICALS, INC. Tender Offer Communication | RCKT SEC Filing - Form SC TO-C - Stock Titan

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) Is Down 8.9% After FDA Accelerated Approval Of KRESLADI Gene Therapy - Yahoo Finance

Rocket Pharmaceuticals (RCKT) Is Down 8.9% After FDA Accelerated Approval Of KRESLADI Gene Therapy  Yahoo Finance

Rocket Pharmaceuticals (RCKT) Is Down 8.9% After FDA Accelerated Approval Of KRESLADI Gene Therapy - Yahoo Finance

Click here to get full coverage on FDA approves first gene therapy for children with severe LAD-I - Stock Titan

FDA approves first gene therapy for children with severe LAD-I  Stock Titan

FDA approves first gene therapy for children with severe LAD-I - Stock Titan

Click here to get full coverage on Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now? - Yahoo Finance

Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now?  Yahoo Finance

Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now? - Yahoo Finance

Click here to get full coverage on RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy - Yahoo Finance

RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy  Yahoo Finance

RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy - Yahoo Finance

Click here to get full coverage on Here's Why We're Watching Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Situation - Yahoo Finance

Here's Why We're Watching Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Situation  Yahoo Finance

Here's Why We're Watching Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Situation - Yahoo Finance

Click here to get full coverage on Needham Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating - 富途牛牛

Needham Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating  富途牛牛

Needham Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating - 富途牛牛

Click here to get full coverage on Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Stock Price Today & Analysis - Gotrade

Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Stock Price Today & Analysis  Gotrade

Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Stock Price Today & Analysis - Gotrade

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) Launches $100 Million Stock Offeri - GuruFocus

Rocket Pharmaceuticals (RCKT) Launches $100 Million Stock Offeri  GuruFocus

Rocket Pharmaceuticals (RCKT) Launches $100 Million Stock Offeri - GuruFocus

Click here to get full coverage on Rocket Pharmaceuticals (NASDAQ: RCKT) files $400M shelf to raise capital - Stock Titan

Rocket Pharmaceuticals (NASDAQ: RCKT) files $400M shelf to raise capital  Stock Titan

Rocket Pharmaceuticals (NASDAQ: RCKT) files $400M shelf to raise capital - Stock Titan

Click here to get full coverage on RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus - Yahoo Finance

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus  Yahoo Finance

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus - Yahoo Finance

Click here to get full coverage on Assessing Rocket Pharmaceuticals (RCKT) Valuation After Accelerated FDA Approval Of KRESLADI - simplywall.st

Assessing Rocket Pharmaceuticals (RCKT) Valuation After Accelerated FDA Approval Of KRESLADI  simplywall.st

Assessing Rocket Pharmaceuticals (RCKT) Valuation After Accelerated FDA Approval Of KRESLADI - simplywall.st

Click here to get full coverage on Gene therapy company spotlights rare-disease work at J.P. Morgan event - Stock Titan

Gene therapy company spotlights rare-disease work at J.P. Morgan event  Stock Titan

Gene therapy company spotlights rare-disease work at J.P. Morgan event - Stock Titan

Click here to get full coverage on Rocket Pharmaceuticals Stock (RCKT) Opinions on FDA Clinical Hold Lift - Quiver Quantitative

Rocket Pharmaceuticals Stock (RCKT) Opinions on FDA Clinical Hold Lift  Quiver Quantitative

Rocket Pharmaceuticals Stock (RCKT) Opinions on FDA Clinical Hold Lift - Quiver Quantitative

Click here to get full coverage on New Analyst Forecast: $RCKT Given $11 Price Target - Quiver Quantitative

New Analyst Forecast: $RCKT Given $11 Price Target  Quiver Quantitative

New Analyst Forecast: $RCKT Given $11 Price Target - Quiver Quantitative

Click here to get full coverage on $RCKT stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

$RCKT stock is up 10% today. Here's what we see in our data.  Quiver Quantitative

$RCKT stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on RCKT Faces Financial Jutsu Amid Price Target Revaluation - StocksToTrade

RCKT Faces Financial Jutsu Amid Price Target Revaluation  StocksToTrade

RCKT Faces Financial Jutsu Amid Price Target Revaluation - StocksToTrade

Click here to get full coverage on FDA clears Rocket Pharmaceuticals (RCKT) KRESLADI gene therapy and voucher - Stock Titan

FDA clears Rocket Pharmaceuticals (RCKT) KRESLADI gene therapy and voucher  Stock Titan

FDA clears Rocket Pharmaceuticals (RCKT) KRESLADI gene therapy and voucher - Stock Titan

Click here to get full coverage on Vanguard Disaggregates Rocket Pharmaceuticals Holdings (NASDAQ: RCKT) - Stock Titan

Vanguard Disaggregates Rocket Pharmaceuticals Holdings (NASDAQ: RCKT)  Stock Titan

Vanguard Disaggregates Rocket Pharmaceuticals Holdings (NASDAQ: RCKT) - Stock Titan

Click here to get full coverage on Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program - Seeking Alpha

Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program  Seeking Alpha

Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program - Seeking Alpha

Click here to get full coverage on RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study - Yahoo Finance

RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study  Yahoo Finance

RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study - Yahoo Finance

Click here to get full coverage on BofA raises Rocket Pharmaceuticals price target on execution view - Investing.com

BofA raises Rocket Pharmaceuticals price target on execution view  Investing.com

BofA raises Rocket Pharmaceuticals price target on execution view - Investing.com

Click here to get full coverage on Rocket Pharmaceuticals: Kresladi Approval Validates Platform, But Commercial Upside Remains Limited - Seeking Alpha

Rocket Pharmaceuticals: Kresladi Approval Validates Platform, But Commercial Upside Remains Limited  Seeking Alpha

Rocket Pharmaceuticals: Kresladi Approval Validates Platform, But Commercial Upside Remains Limited - Seeking Alpha

Click here to get full coverage on RCKT: B of A Securities Raises Price Target on Buy Rating | RCKT Stock News - GuruFocus

RCKT: B of A Securities Raises Price Target on Buy Rating | RCKT Stock News  GuruFocus

RCKT: B of A Securities Raises Price Target on Buy Rating | RCKT Stock News - GuruFocus

Click here to get full coverage on 100% overall survival at 12 months — Rocket Pharma's KRESLADI BLA accepted; PDUFA Mar 28, 2026 - Stock Titan

100% overall survival at 12 months — Rocket Pharma's KRESLADI BLA accepted; PDUFA Mar 28, 2026  Stock Titan

100% overall survival at 12 months — Rocket Pharma's KRESLADI BLA accepted; PDUFA Mar 28, 2026 - Stock Titan

Click here to get full coverage on Goldman Sachs Maintains 'Sell' Rating on RCKT, Raises Price Targ - GuruFocus

Goldman Sachs Maintains 'Sell' Rating on RCKT, Raises Price Targ  GuruFocus

Goldman Sachs Maintains 'Sell' Rating on RCKT, Raises Price Targ - GuruFocus

Click here to get full coverage on Morgan Stanley reiterates Rocket Pharmaceuticals stock rating on Kresladi approval - Investing.com

Morgan Stanley reiterates Rocket Pharmaceuticals stock rating on Kresladi approval  Investing.com

Morgan Stanley reiterates Rocket Pharmaceuticals stock rating on Kresladi approval - Investing.com

Click here to get full coverage on Rocket Pharma's shares soar after U.S. FDA lets gene therapy trial resume - CNBC

Rocket Pharma's shares soar after U.S. FDA lets gene therapy trial resume  CNBC

Rocket Pharma's shares soar after U.S. FDA lets gene therapy trial resume - CNBC

Click here to get full coverage on Rocket Pharma says gene therapy gets FDA review (RCKT:NASDAQ) - Seeking Alpha

Rocket Pharma says gene therapy gets FDA review (RCKT:NASDAQ)  Seeking Alpha

Rocket Pharma says gene therapy gets FDA review (RCKT:NASDAQ) - Seeking Alpha

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) launches $100M at-the-market stock offering with Cantor - Stock Titan

Rocket Pharmaceuticals (RCKT) launches $100M at-the-market stock offering with Cantor  Stock Titan

Rocket Pharmaceuticals (RCKT) launches $100M at-the-market stock offering with Cantor - Stock Titan

Click here to get full coverage on RCKT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

RCKT Financials: Income Statement, Balance Sheet & Cash Flow  Stock Titan

RCKT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Click here to get full coverage on Rocket Pharmaceuticals Launches $100 Million ATM Offering With Cantor Fitzgerald - TradingView — Track All Markets

Rocket Pharmaceuticals Launches $100 Million ATM Offering With Cantor Fitzgerald  TradingView — Track All Markets

Rocket Pharmaceuticals Launches $100 Million ATM Offering With Cantor Fitzgerald - TradingView — Track All Markets

Click here to get full coverage on Rocket Pharma stock cut at J.P. Morgan (RCKT:NASDAQ) - Seeking Alpha

Rocket Pharma stock cut at J.P. Morgan (RCKT:NASDAQ)  Seeking Alpha

Rocket Pharma stock cut at J.P. Morgan (RCKT:NASDAQ) - Seeking Alpha

Click here to get full coverage on Clinical Hold Lifted: Rocket Pharmaceuticals Cleared to Resume Groundbreaking Danon Disease Gene Therapy Trial - Stock Titan

Clinical Hold Lifted: Rocket Pharmaceuticals Cleared to Resume Groundbreaking Danon Disease Gene Therapy Trial  Stock Titan

Clinical Hold Lifted: Rocket Pharmaceuticals Cleared to Resume Groundbreaking Danon Disease Gene Therapy Trial - Stock Titan

Click here to get full coverage on Possible Signal As Rocket Pharmaceuticals Insiders Sell US$1.1m In Stock - simplywall.st

Possible Signal As Rocket Pharmaceuticals Insiders Sell US$1.1m In Stock  simplywall.st

Possible Signal As Rocket Pharmaceuticals Insiders Sell US$1.1m In Stock - simplywall.st

Click here to get full coverage on RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure - Yahoo Finance

RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure  Yahoo Finance

RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure - Yahoo Finance

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) Stock Pops on Historic FDA Gene Therapy Win - mexc.co

Rocket Pharmaceuticals (RCKT) Stock Pops on Historic FDA Gene Therapy Win  mexc.co

Rocket Pharmaceuticals (RCKT) Stock Pops on Historic FDA Gene Therapy Win - mexc.co

Click here to get full coverage on Will The FDA's Decision On KRESLADI Propel Rocket Pharmaceuticals? - RTTNews

Will The FDA's Decision On KRESLADI Propel Rocket Pharmaceuticals?  RTTNews

Will The FDA's Decision On KRESLADI Propel Rocket Pharmaceuticals? - RTTNews

Click here to get full coverage on Is Rocket Pharmaceuticals (RCKT) the Best Low Priced Biotech Stock to Buy Now? - Yahoo Finance

Is Rocket Pharmaceuticals (RCKT) the Best Low Priced Biotech Stock to Buy Now?  Yahoo Finance

Is Rocket Pharmaceuticals (RCKT) the Best Low Priced Biotech Stock to Buy Now? - Yahoo Finance

Click here to get full coverage on RCKT: Focused on rare cardiac gene therapies, advancing pivotal trials, and exploring partnerships - TradingView — Track All Markets

RCKT: Focused on rare cardiac gene therapies, advancing pivotal trials, and exploring partnerships  TradingView — Track All Markets

RCKT: Focused on rare cardiac gene therapies, advancing pivotal trials, and exploring partnerships - TradingView — Track All Markets

Click here to get full coverage on Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death - Yahoo Finance

Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death  Yahoo Finance

Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death - Yahoo Finance

Click here to get full coverage on Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences  Business Wire

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

Click here to get full coverage on Undervalued Penny Stocks To Consider In January 2026 - simplywall.st

Undervalued Penny Stocks To Consider In January 2026  simplywall.st

Undervalued Penny Stocks To Consider In January 2026 - simplywall.st

Click here to get full coverage on Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress - Business Wire

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress  Business Wire

Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress - Business Wire

Click here to get full coverage on Rocket Pharmaceuticals: Good News As Clinical Hold Lifted - But Challenges Remain (RCKT) - Seeking Alpha

Rocket Pharmaceuticals: Good News As Clinical Hold Lifted - But Challenges Remain (RCKT)  Seeking Alpha

Rocket Pharmaceuticals: Good News As Clinical Hold Lifted - But Challenges Remain (RCKT) - Seeking Alpha

Click here to get full coverage on Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference - Business Wire

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference  Business Wire

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference - Business Wire

Click here to get full coverage on Rocket Pharmaceuticals (RCKT) Downgraded to Underweight by JP Mo - GuruFocus

Rocket Pharmaceuticals (RCKT) Downgraded to Underweight by JP Mo  GuruFocus

Rocket Pharmaceuticals (RCKT) Downgraded to Underweight by JP Mo - GuruFocus

Click here to get full coverage on ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) SHAREHOLDER - GlobeNewswire

ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) SHAREHOLDER  GlobeNewswire

ROCKET PHARMACEUTICALS, INC. (NASDAQ: RCKT) SHAREHOLDER - GlobeNewswire

Click here to get full coverage on RCKT 260417 7.50P (RCKT260417P7500) Stock Options Chain & Price - Moomoo

RCKT 260417 7.50P (RCKT260417P7500) Stock Options Chain & Price  Moomoo

RCKT 260417 7.50P (RCKT260417P7500) Stock Options Chain & Price - Moomoo

Click here to get full coverage on RCKT Shares Fall Even After FDA Approves Gene Therapy for Uncommon Disease - Bitget

RCKT Shares Fall Even After FDA Approves Gene Therapy for Uncommon Disease  Bitget

RCKT Shares Fall Even After FDA Approves Gene Therapy for Uncommon Disease - Bitget

Click here to get full coverage on Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026 - Seeking Alpha

Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026  Seeking Alpha

Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026 - Seeking Alpha

Click here to get full coverage on Rocket Pharmaceuticals enters $100 million at-the-market offering agreement - Investing.com

Rocket Pharmaceuticals enters $100 million at-the-market offering agreement  Investing.com

Rocket Pharmaceuticals enters $100 million at-the-market offering agreement - Investing.com

Click here to get full coverage on Rocket Pharmaceuticals' (RCKT) Financial Position at Year-End - GuruFocus

Rocket Pharmaceuticals' (RCKT) Financial Position at Year-End  GuruFocus

Rocket Pharmaceuticals' (RCKT) Financial Position at Year-End - GuruFocus

Click here to get full coverage on Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - Business Wire

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress  Business Wire

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress - Business Wire

Click here to get full coverage on Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease Blow - Yahoo Finance

Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease Blow  Yahoo Finance

Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease Blow - Yahoo Finance

Click here to get full coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) Nasdaq Index Drives Rare-Disease Research - Kalkine Media

Rocket Pharmaceuticals (NASDAQ:RCKT) Nasdaq Index Drives Rare-Disease Research  Kalkine Media

RCKT

Price Chart

Key Statistics

Technicals

About RCKT

Latest News

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease - Zacks Investment Research

RCKT (Rocket Pharmaceuticals) asks shareholders to elect directors, ratify auditor, approve option exchange - Stock Titan

Morgan Stanley Names Rocket Pharmaceuticals (RCKT) as Key Beneficiary of 2026 Biotech Sector Recovery - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers